Detection of human herpesvirus 8 DNA and antibodies to latent nuclear and lytic-phase antigens in serial samples from aids patients with Kaposi's sarcoma
Lc. Pierrotti et al., Detection of human herpesvirus 8 DNA and antibodies to latent nuclear and lytic-phase antigens in serial samples from aids patients with Kaposi's sarcoma, J CLIN VIRO, 16(3), 2000, pp. 247-251
Background: human herpesvirus 8 (HHV-8) have recently implicated in the eti
ology of Kaposi's sarcoma (KS), but the pathophysiologic and immunologic in
teractions between HHV-8 and the human host are incompletely understood. Ob
jective: this paper intends to present partial results of a follow-up study
of KS patients, designed to investigate HHV-8 viremia and antibody respons
e. Methods: ninety-six paired serial samples (PBMCs and sera) were obtained
from 12 aids patients with KS who received HAART prior or just after entry
in the study. HHV-8 DNA was detected by nested-PCR and antibodies to HHV-8
latent nuclear antigen (LANA) and lytic antigen by immunofluorescence assa
y (IFA). Results: HHV-8 DNA was detected in 33.3% of the first PBMC samples
. Among the eight PCR negative patients, four presented positive samples du
ring the follow-up and four remained negative. Five patients had intermitte
nt viremia. Fifteen of the 96 PBMC samples were PCR positive (15.6%). Four
of 39 samples (10.2%) from patients classified as stadio II and 11 of the 5
3 samples (20.7%) from patients in stadio IV were PCR positive (P = 0.2). S
ix patients (50%) had anti-LANA antibodies at the entry in the study. Among
the six seronegative patients, two seroconverted 2 months later and four p
atients remained seronegative during the 5-8 months of follow-up. All patie
nts had anti-lytic antibodies since the first sample. Conclusion: the prese
nce of HHV-8 viremia could be related to the severity of KS and could be in
termittent even under HAART. A longer follow-up is needed to confirm these
results. (C) 2000 Elsevier Science B.V. All rights reserved.